Hydroxymethylation- and methylation-sensitive tag sequencing: How will this technology change clinical applications of DNA methylation profiling?

Epigenomics

Volumn 5, Issue 4, 2013, Pages 355-357

  Gao, Fei ^a   Xia, Yudong ^a  

^a BGI SHENZHEN   (China)

Author keywords

clinical application; DNA hydroxymethylation; DNA methylation; HMST seq

Indexed keywords

BIOLOGICAL MARKER;

DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; GENE MUTATION; HUMAN; PRIORITY JOURNAL; REVIEW;

DNA FINGERPRINTING; DNA METHYLATION; EPIGENESIS, GENETIC; GENETIC LOCI; GENETIC MARKERS; HUMANS;

EID: 84881111958     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.13.33     Document Type: Review

References (19)

1. Klose RJ, Bird AP. Genomic DNA methylation: The mark and its mediators. Trends Biochem. Sci. 31(2), 89-97 (2006
2. Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324(5929), 929-930 (2009
3. Tahiliani M, Koh KP, Shen Y et al Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929), 930-935 (2009
4. Ito S, Shen L, Dai Q et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333(6047), 1300-1303 (2011
5. Nestor C, Ruzov A, Meehan R, Dunican D. Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques 48(4), 317-319 (2010
6. Gao F, Xia Y, Wang J et al. Integrated detection of both 5-mC and 5-hmC by high-Throughput tag sequencing technology highlights methylation reprogramming of bivalent genes during cellular differentiation. Epigenetics 8(4), 421-430 (2013
7. Booth MJ, Branco MR, Ficz G et al. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 336(6083), 934-937 (2012
8. Yu M, Hon GC, Szulwach KE et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 149(6), 1368-1380 (2012
9. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 25(10), 1010-1022 (2011
10. Wu T, Giovannucci E, Welge J, Mallick P, Tang WY, Ho SM. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: A meta-Analysis. Br. J. Cancer 105(1), 65-73 (2011
11. Hegi ME, Diserens AC, Gorlia T et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med. 352(10), 997-1003 (2005
12. Heyn H, Esteller M. DNA methylation profiling in the clinic: Applications and challenges. Nat. Rev. Genet. 13(10), 679-692 (2012
13. Baylin SB, Jones PA. A decade of exploring the cancer epigenome-biological and translational implications. Nat. Rev. Cancer 11(10), 726-734 (2011
14. Kinney SM, Chin HG, Vaisvila R et al. Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes. J. Biol. Chem. 286(28), 24685-24693 (2011
15. Jin SG, Jiang Y, Qiu R et al. 5-hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res. 71(24), 7360-7365 (2011
16. Hitchins MP, Rapkins RW, Kwok CT et al. Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-Affected family is linked to a single nucleotide variant within the 5́UTR. Cancer Cell 20(2), 200-213 (2011
17. Teng IW, Hou PC, Lee KD et al. Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res. 71(13), 4653-4663 (2011
18. Rivenbark AG, Stolzenburg S, Beltran AS et al. Epigenetic reprogramming of cancer cells via targeted DNA methylation. Epigenetics 7(4), 350-360 (2012
19. Gregory DJ, Mikhaylova L, Fedulov AV. Selective DNA demethylation by fusion of TDG with a sequence-specific DNA-binding domain. Epigenetics 7(4), 344-349 (2012